CODX
Co-diagnosticsยทNASDAQ
--
--(--)
--
--(--)
CODX Profile
Co-Diagnostics, Inc.
The leading U.S. PCR molecular diagnostics company, specializing in rapid infectious disease nucleic acid testing and precision diagnostic technology R&D
Healthcare Equipment and Supplies
04/18/2013
03/11/2026
NASDAQ Stock Exchange
132
12-31
Common stock
2401 S. Foothill Drive, Salt Lake City, Utah 84109
--
Co-diagnostics, Inc., founded on April 18, 2013, is a Utah company headquartered in Salt Lake City, Utah, and is a molecular diagnostic company that has developed and intends to sell molecular diagnostic technologies such as laboratory systems, and manufactures and sells reagents for testing or analytically designed tests using nucleic acid molecules (DNA or RNA).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
